Description
Samlet 2.5 Tablet 5’s, a potent pharmaceutical solution, contains the active ingredient Letrozole, a selective aromatase inhibitor. This medication is primarily indicated for the adjuvant treatment of postmenopausal women with hormone-receptor positive early breast cancer, following surgery and radiation therapy. By inhibiting the conversion of androgens to estrogens, Samlet helps reduce the risk of cancer recurrence. Each tablet contains 2.5mg of Letrozole and is designed for oral administration. Consult your healthcare provider for proper dosage and usage instructions to ensure optimal therapeutic benefits.
Reviews
There are no reviews yet.